HOME
LOGIN/REGISTER
THE MEDICAL LETTER
Subscribe
Current Issue
Previous Issues
Most Read Articles
ABOUT US
The Medical Letter, Inc.
CONTINUING EDUCATION
Exams
CONTACT US
The Medical Letter Mobile Home Page
CURRENT
ISSUE
1502
The FDA has approved AspireAssist (Aspire Bariatrics), a weight-loss device that permits patients to drain a portion of their stomach contents through a gastrostomy tube into a toilet after each meal. It is approved for long-term use in combination with lifestyle modifications in adults ≥22 years old who have a body mass index (BMI) of 35 to 55 and have not been able to achieve and maintain weight loss with nonsurgical...  read more...
More from issue 1502
Coming Soon
Byvalson - A New Combination for Hypertension
A New Formulation of Evolocumab (Repatha Pushtronex) to Lower LDL-Cholesterol
Daclizumab (Zinbryta) for Multiple Sclerosis
In Brief: An OTC Retinoid for Acne
Previous Issues
© 2016 The Medical Letter, Inc.